Published in J Clin Oncol on July 01, 1998
Cancer chemotherapy and body surface area. J Clin Oncol (1998) 0.82
Chemotherapy of advanced non-small-cell lung cancer: "Those who cannot remember the past are condemned to repeat it". J Clin Oncol (1999) 0.75
Oligometastases. J Clin Oncol (1995) 4.95
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol (1989) 2.71
Radiation therapy of early carcinoma of the breast without mastectomy. Cancer (1980) 2.49
Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys (1979) 2.10
Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer (1993) 2.07
Stopping metastases at their source. N Engl J Med (1997) 2.03
Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95
Hodgkin's disease: evidence for a tumor-associated antigen. N Engl J Med (1971) 1.83
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol (2000) 1.78
Pathogenesis of Hodgkin's disease. Lancet (1972) 1.77
Proliferative capacity of murine hematopoietic stem cells. Proc Natl Acad Sci U S A (1978) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Spatial and temporal control of gene therapy using ionizing radiation. Nat Med (1995) 1.59
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol (1995) 1.59
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol (1989) 1.57
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res (2000) 1.55
Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am (2006) 1.54
Considerations in the radiation therapy of Wilms' tumor. Cancer (1973) 1.51
Race and the Will Rogers phenomenon in prostate cancer. Cancer J Sci Am (1998) 1.50
Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am (1997) 1.48
Limited surgery and radiotherapy for early breast cancer. N Engl J Med (1985) 1.48
Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood (1989) 1.45
It's too soon to know. J Natl Cancer Inst (1990) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Effects of noise and noise suppression on speech perception by cochlear implant users. Ear Hear (1992) 1.40
The benefits of mammography are not limited to women of ages older than 50 years. Cancer (1998) 1.39
The key and the lamppost. J Clin Oncol (1999) 1.39
Advances in radiation oncology. Lancet (1997) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures. Proc Natl Acad Sci U S A (1980) 1.38
A piece of my mind. Tales of the unnatural: return from the dean(d) JAMA (1998) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery (1989) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Radiation therapy as initial treatment for early stage cancer of the breast without mastectomy. Cancer (1977) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Nature of the hemopoietic stem cell compartment and its proliferative potential. Blood Cells (1979) 1.26
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol (1997) 1.24
Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation (1988) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Studies of antigens associated with Hodgkin's disease. Blood (1972) 1.18
Treatment of carcinoma of the breast by radiation therapy. Cancer (1977) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res (1998) 1.13
The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res (1972) 1.12
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst (1996) 1.11
Results of treating stage III carcinoma of the breast by primary radiation therapy. Cancer (1979) 1.09
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood (1988) 1.07
The significance of mediastinal involvement in early stage Hodgkin's disease. Cancer (1978) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Stem cell depletion: an explanation of the late effects of cytotoxins. Int J Radiat Oncol Biol Phys (1977) 1.04
Normal tissue responses to radiation therapy. N Engl J Med (1975) 1.03
Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine. Cancer Res (1978) 1.02
Clinical-pathologic study of early breast cancer treated by primary radiation therapy. J Clin Oncol (1983) 1.01
Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys (1985) 1.01
Primary radiation therapy for early breast cancer: the experience at The Joint Center for Radiation Therapy. Int J Radiat Oncol Biol Phys (1981) 1.01
Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer. J Clin Oncol (1984) 1.01
Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy. Br J Cancer (1984) 1.00
Haematopoietic stem cells: evidence for competing proliferative demands. Nature (1967) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet (1984) 0.98
Decline in bone marrow proliferative capacity as a function of age. Blood (1982) 0.98
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Res (1996) 0.98
Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res (1981) 0.97
Improvement in quality of survival following whole-brain irradiation for brain metastasis. Radiology (1968) 0.96
Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer (2000) 0.93
Aging, progression, and phenotype in breast cancer. J Clin Oncol (1998) 0.93
Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol (1993) 0.93
The effect of compression ratio and release time on the categorical rating of sound quality. J Acoust Soc Am (1998) 0.93
Observations on survival curve analysis with particular reference to breast cancer treatment. Cancer (1986) 0.91
Preferred listening levels for linear and slow-acting compression hearing aids. Ear Hear (1995) 0.91
The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg (1985) 0.91
Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol (1985) 0.91
Cosmetic results following primary radiation therapy for early breast cancer. Cancer (1984) 0.90
Total body irradiation as treatment for lymphosarcoma. Int J Radiat Oncol Biol Phys (1976) 0.90
Multisystem stem cell failure after apparent recovery from alkylating agents. Cancer Res (1978) 0.89
The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol (1987) 0.89
Distribution of fast- and slow-migrating Hodgkin's tumor-associated antigens. Cancer Res (1974) 0.89
Limited proliferation of stem cells surviving alkylating agents. Nature (1976) 0.89
Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant (1994) 0.89
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther (2008) 0.89
Current studies in Hodgkin's disease: what laparotomy has wrought. N Engl J Med (1974) 0.89
A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents. Int J Radiat Oncol Biol Phys (1979) 0.88
Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease. Cancer Treat Rep (1982) 0.88
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol (1996) 0.88
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res (2000) 0.88
Cancer of the esophagus: a brighter future? J Clin Oncol (1984) 0.88
The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer. Cancer Res (1998) 0.87
Radionuclide immunoglobulin lymphangiography: a case report. Cancer (1975) 0.87
Limited resection for breast cancer: a study of inked specimen margins before radiotherapy. Int J Radiat Oncol Biol Phys (1987) 0.87
Effect of compression ratio in a slow-acting compression hearing aid: paired-comparison judgments of quality. J Acoust Soc Am (1994) 0.86
Engraftment following T-cell-depleted marrow transplantation. I. The role of major and minor histocompatibility barriers. Transplantation (1987) 0.86
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Occasional notes. The management of early breast cancer. N Engl J Med (1982) 0.85
Anatomic substages of stage III-A Hodgkin's disease. A collaborative study. Ann Intern Med (1980) 0.85
Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man. Int J Radiat Oncol Biol Phys (1987) 0.85
Sequential chemotherapy and radiotherapy. Preliminary results of clinical trial with methotrexate in head and neck cancer. Radiology (1966) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Passive smoking among schoolchildren in Israel. Environ Health Perspect (1991) 0.85